nitrates has been researched along with Hyperlipidemias in 19 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We administered simvastatin, 20 mg daily, to 27 patients with hypercholesterolemia and coronary artery disease, or fenofibrate, 200 mg daily, to 27 patients with pure hypertriglyceridemia during 8 weeks." | 5.11 | Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia. ( Ahn, JY; Ahn, TH; Choi, IS; Han, SH; Jeong, EM; Jin, DK; Kim, HS; Koh, KK; Shin, EK, 2004) |
| "Approximately 1 in 5 hospitalized COPD patients are readmitted within 30 days of discharge." | 2.82 | Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions? ( Bowlin, B; Finch, C; Hartmann, J; Reedus, J; Richardson, A; Sands, CW; Self, T; Tolley, E, 2016) |
| "The effect of experimental hyperlipidemia on functional activity of macrophages was studied in CBA and C57Bl/6 mice resistant and sensitive to the formation of aorta lesions, respectively." | 1.31 | Effect of hyperlipidemia on functional activity of peritoneal macrophages in CBA and C57Bl/6 mice. ( Kiseleva, EP; Kovaleva, IG; Ogurtsov, RP; Puzyreva, VP, 2002) |
| " After further adjustments by percentage of men, age structure, geographical location (mid-points) of the municipalities, and, as a proxy for cardiovascular disease, the sales of cardiovascular drugs other than the tested drug group, the increased risk associated with blood pressure lowering drugs disappeared, and there was a dose-response association between sales of diuretics and old antihypertensives and decreasing mortality, sales of nitrates continued to be associated with an increased risk, and the low mortality risk associated with sales of lipid lowering drugs persisted." | 1.30 | Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalities. ( Lindberg, G; Lindblad, U; Lindgren, A; Melander, A; Merlo, J; Råstam, L, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Namwong, A | 1 |
| Kumphune, S | 1 |
| Seenak, P | 1 |
| Chotima, R | 1 |
| Nernpermpisooth, N | 1 |
| Malakul, W | 1 |
| Richardson, A | 1 |
| Tolley, E | 1 |
| Hartmann, J | 1 |
| Reedus, J | 1 |
| Bowlin, B | 1 |
| Finch, C | 1 |
| Sands, CW | 1 |
| Self, T | 1 |
| Lopes Krüger, R | 1 |
| Costa Teixeira, B | 1 |
| Boufleur Farinha, J | 1 |
| Cauduro Oliveira Macedo, R | 1 |
| Pinto Boeno, F | 1 |
| Rech, A | 1 |
| Lopez, P | 1 |
| Silveira Pinto, R | 1 |
| Reischak-Oliveira, A | 1 |
| Derosa, G | 1 |
| Ferrari, I | 1 |
| D'Angelo, A | 1 |
| Salvadeo, SA | 1 |
| Fogari, E | 1 |
| Gravina, A | 1 |
| Mereu, R | 1 |
| Palumbo, I | 1 |
| Maffioli, P | 1 |
| Randazzo, S | 1 |
| Cicero, AF | 1 |
| Bell, HK | 1 |
| Bloomer, RJ | 1 |
| Hirowatari, Y | 1 |
| Kurosawa, H | 1 |
| Yoshida, H | 1 |
| Doumitu, KI | 1 |
| Tada, N | 1 |
| Kiseleva, EP | 1 |
| Puzyreva, VP | 1 |
| Ogurtsov, RP | 1 |
| Kovaleva, IG | 1 |
| Dietz, R | 1 |
| Rauch, B | 1 |
| Koh, KK | 1 |
| Ahn, JY | 1 |
| Jin, DK | 1 |
| Han, SH | 1 |
| Kim, HS | 1 |
| Choi, IS | 1 |
| Ahn, TH | 1 |
| Shin, EK | 1 |
| Jeong, EM | 1 |
| Vidonho, AF | 1 |
| da Silva, AA | 1 |
| Catanozi, S | 1 |
| Rocha, JC | 1 |
| Beutel, A | 1 |
| Carillo, BA | 1 |
| Furukawa, LN | 1 |
| Campos, RR | 1 |
| de Toledo Bergamaschi, CM | 1 |
| Carpinelli, AR | 1 |
| Quintão, EC | 1 |
| Dolnikoff, MS | 1 |
| Heimann, JC | 1 |
| Andreassi, MG | 1 |
| Botto, N | 1 |
| Simi, S | 1 |
| Casella, M | 1 |
| Manfredi, S | 1 |
| Lucarelli, M | 1 |
| Venneri, L | 1 |
| Biagini, A | 1 |
| Picano, E | 1 |
| Higashino, H | 1 |
| Miya, H | 1 |
| Mukai, H | 1 |
| Miya, Y | 1 |
| Komiyama, Y | 1 |
| Kimura, Y | 1 |
| Nishimura, N | 1 |
| Hara, K | 1 |
| Mori, T | 1 |
| Okuda, K | 1 |
| Munakata, M | 1 |
| Masuda, M | 1 |
| Murakami, T | 1 |
| Takahashi, H | 1 |
| Minamino, T | 1 |
| Kitakaze, M | 1 |
| Sato, H | 1 |
| Asanuma, H | 1 |
| Funaya, H | 1 |
| Koretsune, Y | 1 |
| Hori, M | 1 |
| Merlo, J | 1 |
| Lindberg, G | 1 |
| Lindblad, U | 1 |
| Lindgren, A | 1 |
| Råstam, L | 1 |
| Melander, A | 1 |
| Hayashi, T | 1 |
| Yamada, K | 1 |
| Esaki, T | 1 |
| Kano, H | 1 |
| Asai, Y | 1 |
| Kumar Thakur, N | 1 |
| Jayachandran, M | 1 |
| Sumi, D | 1 |
| Iguchi, A | 1 |
| Matsuzaki, M | 1 |
| Fujii, T | 1 |
| Duplain, H | 1 |
| Burcelin, R | 1 |
| Sartori, C | 1 |
| Cook, S | 1 |
| Egli, M | 1 |
| Lepori, M | 1 |
| Vollenweider, P | 1 |
| Pedrazzini, T | 1 |
| Nicod, P | 1 |
| Thorens, B | 1 |
| Scherrer, U | 1 |
| Likoff, W | 1 |
4 trials available for nitrates and Hyperlipidemias
| Article | Year |
|---|---|
Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme I | 2016 |
Effect of exercise intensity on postprandial lipemia, markers of oxidative stress, and endothelial function after a high-fat meal.
Topics: Biomarkers; Brazil; Cardiovascular Diseases; Diet, High-Fat; Endothelium, Vascular; Exercise; Exerci | 2016 |
Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects.
Topics: Adiponectin; Adult; Biomarkers; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet | 2010 |
Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia.
Topics: Brachial Artery; Coronary Artery Disease; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemi | 2004 |
15 other studies available for nitrates and Hyperlipidemias
| Article | Year |
|---|---|
Pineapple fruit improves vascular endothelial dysfunction, hepatic steatosis, and cholesterol metabolism in rats fed a high-cholesterol diet.
Topics: Ananas; Animals; Antioxidants; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet; Fatty Liver; Frui | 2022 |
Impact of serum estradiol on postprandial lipemia, oxidative stress, and inflammation across a single menstrual cycle.
Topics: Adolescent; Adult; Analysis of Variance; Antioxidants; Area Under Curve; C-Reactive Protein; Chroman | 2010 |
Analysis method for lipoproteins by high-performance liquid chromatography with sulfopropyl-ligand column and magnesium ion-containing eluents.
Topics: Automation; Cholesterol; Cholesterol Oxidase; Chromatography, High Pressure Liquid; Humans; Hyperlip | 2002 |
Effect of hyperlipidemia on functional activity of peritoneal macrophages in CBA and C57Bl/6 mice.
Topics: Animals; Aorta; Diet, Atherogenic; Hyperlipidemias; Lipids; Macrophages, Peritoneal; Male; Mice; Mic | 2002 |
[Guidelines for diagnosis and treatment of chronic coronary heart disease. Issued by the executive committee of the German Society of Cardiology--Heart Circulation Research in cooperation with the German Society for Prevention and Rehabilitation of Cardia
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Angiotensin-Converting | 2003 |
Perinatal salt restriction: a new pathway to programming insulin resistance and dyslipidemia in adult wistar rats.
Topics: Age Factors; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Female; Hyperlipidemias; | 2004 |
Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease.
Topics: Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; DN | 2005 |
Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
Topics: Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aging; Biomarkers; Blood Pressure; Ca | 2007 |
Vasodepressor effects of exercise are accompanied by reduced circulating ouabainlike immunoreactivity and normalization of nitric oxide synthesis.
Topics: Adult; Aged; Blood Pressure; Cardenolides; Chromatography, High Pressure Liquid; Diabetes Mellitus; | 1997 |
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Di | 1997 |
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalities.
Topics: Antihypertensive Agents; Cardiovascular Agents; Cerebrovascular Disorders; Data Collection; Female; | 1999 |
Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-)).
Topics: Acetylcholine; Animals; Arteriosclerosis; Chromatography, High Pressure Liquid; Culture Techniques; | 1999 |
[Prevention of recurrence of myocardial infarction].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Female; Humans; Hyperlipidemias; Male; Myocar | 2000 |
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.
Topics: Animals; Arteries; Blood Flow Velocity; Blood Glucose; Body Weight; Disease Models, Animal; Glucose; | 2001 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die | 1972 |